Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes

Circulation

Volumn 134, Issue 16, 2016, Pages 1130-1140

  Swiryn, Steven ^a   Orlov, Michael V ^b   Benditt, David G ^c   Dimarco, John P ^d   Lloyd Jones, Donald M ^a   Karst, Edward ^e   Qu, Fujian ^e   Slawsky, Mara T ^b   Turkel, Melanie ^e   Waldo, Albert L ^f  

^a NORTHWESTERN UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e ST JUDE MEDICAL   (United States)

^f UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

anti coagulation; atrial fibrillation; defibrillators; pacemakers; stroke; trials

Indexed keywords

AGED; ARTICLE; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; ELECTROGRAPHY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PACEMAKER; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA; AMBULATORY ELECTROCARDIOGRAPHY; ARTIFICIAL HEART PACEMAKER; CASE CONTROL STUDY; COMORBIDITY; DISEASE MANAGEMENT; HEALTH SURVEY; MIDDLE AGED; MORTALITY; ODDS RATIO; REGISTER; TACHYCARDIA; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; DISEASE MANAGEMENT; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; ODDS RATIO; PACEMAKER, ARTIFICIAL; POPULATION SURVEILLANCE; REGISTRIES; TACHYCARDIA; UNITED STATES;

EID: 84991761812     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.020252     Document Type: Article

References (24)

1. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation. Chest. 2010;137:263-272. doi: 10.1378/chest.09-1584.
2. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P; ESC Committee for Practice Guidelines (CPG). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33:2719-2747. doi: 10.1093/eur-heartj/ehs253.
3. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64:e1-e76. doi: 10.1016/j.jacc.2014.03.022.
4. Binici Z, Intzilakis T, Nielsen OW, Køber L, Sajadieh A. Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke. Circulation. 2010;121:1904-1911. doi: 10.1161/CIRCULATIONAHA.109.874982.
5. Larsen BS, Kumarathurai P, Falkenberg J, Nielsen OW, Sajadieh A. Excessive atrial ectopy and short atrial runs increase the risk of stroke beyond incident atrial fibrillation. J Am Coll Cardiol. 2015;66:232-241. doi: 10.1016/j.jacc.2015.05.018.
6. Engström G, Hedblad B, Juul-Möller S, Tydén P, Janzon L. Cardiac arrhythmias and stroke: increased risk in men with high frequency of atrial ectopic beats. Stroke. 2000;31:2925-2929.
7. Pollak WM, Simmons JD, Interian A, Atapattu SA, Castellanos A, Myerburg RJ, Mitrani RD. Clinical utility of intraatrial pacemaker stored electrograms to diagnose atrial fibrillation and flutter. Pacing and Clinical Electrophysiology. 2001;24:424-429.
8. Israel CW, Neubauer H, Olbrich HG, Hartung W, Treusch S, Hohnloser SH; BEATS Study investigators. Incidence of atrial tachyarrhythmias in pacemaker patients: results from the Balanced Evaluation of Atrial Tachyarrhythmias in Stimulated patients (BEATS) study. Pacing Clin Electrophysiol. 2006;29:582-588. doi: 10.1111/j.1540-8159.2006.00405.x.
9. Boriani G, Glotzer TV, Santini M, West TM, De Melis M, Sepsi M, Gasparini M, Lewalter T, Camm JA, Singer DE. Device-detected atrial fibrillation and risk for stroke: an analysis of <10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices). Eur Heart J. 2014;35:508-516. doi: 10.1093/eurheartj/eht491.
10. RATE-Steering-Committee. Registry of atrial tachycardia and atrial fibrillation episodes in the cardiac rhythm management device population: The rate registry design. Am. Heart J. 2009;157:983-987.
11. Orlov MV, Ghali JK, Araghi-Niknam M, Sherfesee L, Sahr D, Hettrick DA; Atrial High Rate Trial investigators. Asymptomatic atrial fibrillation in pacemaker recipients: incidence, progression, and determinants based on the atrial high rate trial. Pacing Clin Electrophysiol. 2007;30:404-411. doi: 10.1111/j.1540-8159.2007.00682.x.
12. Botto GL, Padeletti L, Santini M, Capucci A, Gulizia M, Zolezzi F, Favale S, Molon G, Ricci R, Biffi M, Russo G, Vimercati M, Corbucci G, Boriani G. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol. 2009;20:241-248. doi: 10.1111/j.1540-8167.2008.01320.x.
13. Glotzer TV, Hellkamp AS, Zimmerman J, Sweeney MO, Yee R, Ma-rinchak R, Cook J, Paraschos A, Love J, Radoslovich G, Lee KL, Lamas GA; MOST investigators. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation. 2003;107:1614-1619. doi: 10.1161/01. CIR.0000057981.70380.45.
14. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, D'Agostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ. Lifetime risk for development of atrial fibrillation: the Fram-ingham Heart Study. Circulation. 2004;110:1042-1046. doi: 10.1161/01.CIR.0000140263.20897.42.
15. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Ca-pucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH; ASSERT investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366:120-129. doi: 10.1056/NEJMoa1105575.
16. Kaufman ES, Israel CW, Nair GM, Armaganijan L, Divakarame-non S, Mairesse GH, Brandes A, Crystal E, Costantini O, Sandhu RK, Parkash R, Connolly SJ, Hohnloser SH, Healey JS; ASSERT Steering Committee and investigators. Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: an analysis from ASSERT. Heart Rhythm. 2012;9:1241- 1246. doi: 10.1016/j.hrthm.2012.03.017.
17. Capucci A, Santini M, Padeletti L, Gulizia M, Botto G, Boriani G, Ricci R, Favale S, Zolezzi F, Di Belardino N, Molon G, Drago F, Villani GQ, Mazzini E, Vimercati M, Grammatico A; Italian AT500 Registry investigators. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycar-dia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol. 2005;46:1913-1920. doi: 10.1016/j. jacc.2005.07.044.
18. Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C, Miller C, Qi D, Ziegler PD. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol. 2009;2:474-480. doi: 10.1161/CIRCEP.109.849638.
19. Shanmugam N, Boerdlein A, Proff J, Ong P, Valencia O, Maier SK, Bauer WR, Paul V, Sack S. Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population. Europace. 2012;14:230-237. doi: 10.1093/europace/eur293.
20. Martin DT, Bersohn MM, Waldo AL, Wathen MS, Choucair WK, Lip GY, Ip J, Holcomb R, Akar JG, Halperin JL; IMPACT investigators. Randomized trial of atrial arrhythmia monitoring to guide antico-agulation in patients with implanted defibrillator and cardiac re-synchronization devices. Eur Heart J. 2015;36:1660-1668. doi: 10.1093/eurheartj/ehv115.
21. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-988.
22. Sherman DG, Kim SG, Boop BS, Corley SD, Dimarco JP, Hart RG, Haywood LJ, Hoyte K, Kaufman ES, Kim MH, Nasco E, Waldo AL; National Heart, Lung, and Blood Institute AFFIRM investigators. Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study. Arch Intern Med. 2005;165:1185-1191. doi: 10.1001/archinte.165.10.1185.
23. Daoud EG, Glotzer TV, Wyse DG, Ezekowitz MD, Hilker C, Koehler J, Ziegler PD; TRENDS investigators. Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS. Heart Rhythm. 2011;8:1416-1423. doi: 10.1016/j.hrthm.2011.04.022.
24. Brambatti M, Connolly SJ, Gold MR, Morillo CA, Capucci A, Muto C, Lau CP, Van Gelder IC, Hohnloser SH, Carlson M, Fain E, Naka-mya J, Mairesse GH, Halytska M, Deng WQ, Israel CW, Healey JS; ASSERT investigators. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation. 2014;129:2094- 2099. doi: 10.1161/CIRCULATIONAHA.113.007825.